Diffusion- and T2-weighted MR imaging of the liver: Effect of intravenous administration of gadoxetic acid disodium

Magnetic Resonance in Medical Sciences

Volumn 11, Issue 3, 2012, Pages 185-191

  Muhi, Ali ^a   Ichikawa, Tomoaki ^a   Motosugi, Utaroh ^a   Sou, Hironobu ^a   Sano, Katsuhiro ^a   Araki, Tsutomu ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Diffusion weighted MR imaging; Gadoxetic acid; T2 weighted MR imaging

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; GADOXETIC ACID;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; IMAGE ENHANCEMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRAVENOUS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84867878690     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.11.185     Document Type: Article

References (17)

1. Vogl TJ, Kuämmel S, Hammerstingl R, et al. Liver tumors: comparison ofMR imaging with Gd-EOBDTPA and Gd-DTPA. Radiology 1996; 200:59-67.
2. Tanimoto A, Satoh Y, Yuasa Y, Jinzaki M, Hiramatsu K. Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: a comparative study by alternative free-response receiver operating characteristic analysis. J Magn Reson Imaging 1997; 7:120-124.
3. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 2005; 234:468-478.
4. Jung G, Breuer J, Poll LW, et al. Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA. Acta Radiol 2006; 47:15-23.
5. Halavaara J, Breuer J, Ayuso C, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT-a multicenter trial. J Comput Assist Tomogr 2006; 30:345-354.
6. Hamm B, Staks T,Muähler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195:785-792.
7. Reimer P, Rummeny EJ, Shamsi K, et al. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 1996; 199: 177-183.
8. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007; 6:43-52.
9. Motosugi U, Ichikawa T, Tominaga L, et al. Delay before the hepatocyte phase of Gd-EOB-DTPAenhanced MR imaging: is it possible to shorten the examination time? Eur Radiol 2009; 19:2623-2629.
10. Menu Y. Hepatocellular carcinoma: radiological findings. Hepatogastroenterology. 1998; 45 Suppl 3:1232-1235.
11. Hussain SM, Zondervan PE, Ijzermans JN, Schalm SW, de Man RA, Krestin GP. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 2002; 22:1023-1036; discussion 1037-1039.
12. Yu SC, Yeung DT, So NM. Imaging features of hepatocellular carcinoma. Clin Radiol 2004; 59: 145-156.
13. Elsayes KM, Narra VR, Yin Y, Mukundan G, Lammle M, Brown JJ. Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging. Radiographics 2005; 25:1299-1320.
14. Choi JS, Kim MJ, Choi JY, Park MS, Lim JS, Kim KW. Diffusion-weighted MR imaging of liver on 3.0-Tesla system: Effect of ntravenous administration of gadoxetic acid disodium. Eur Radiol 2010; 20:1052-1060.
15. 2-weighted MR images before and after the administration of gadoxectic acid. J Magn Reson Imaging 2009; 30:437-443.
16. 2-weighted magnetic resonance imaging of the liver: evaluation of the Effect in signal intensity after Gd-EOBDTPA enhancement. J Comput Assist Tomogr 2010; 34:182-186.
17. 2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma. J Magn Reson Imaging 2010; 32:229-234.